Clinical Trials Directory

Trials / Unknown

UnknownNCT05355610

Vestibular Rehabilitation With Intratympanic Drug Therapy in Meniere's Disease

Objective Vestibular Evaluation & Rehabilitation With Intratympanic Dexamethasone and Gentamicin in Meniere's Disease

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
93 (estimated)
Sponsor
Combined Military Hospital Quetta · Academic / Other
Sex
All
Age
24 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Intractable symptoms of Meniere's disease will be treated with intratympanic steroids. At the same time intratympanic dexamethasone will be used to rescue hearing

Detailed description

For Alleviation of Intractable symptoms of Meniere's disease will be treated with intratympanic steroids. Measured with pre and post therapy vestibular severity index. At the same time intratympanic dexamethasone will be used to rescue hearing measured with speech reception threshold and speech discrimination threshold

Conditions

Interventions

TypeNameDescription
DRUGGentamicinIntratympanic gentamicin and dexamethasone administered in two doses one week apart
DRUGDexamethasoneIntratympanic gentamicin and dexamethasone administered in two doses one week apart

Timeline

Start date
2021-04-01
Primary completion
2022-04-22
Completion
2022-05-30
First posted
2022-05-02
Last updated
2022-05-02

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05355610. Inclusion in this directory is not an endorsement.